143 related articles for article (PubMed ID: 23231881)
21. Influence of mTOR in energy and metabolic homeostasis.
Haissaguerre M; Saucisse N; Cota D
Mol Cell Endocrinol; 2014 Nov; 397(1-2):67-77. PubMed ID: 25109278
[TBL] [Abstract][Full Text] [Related]
22. mTORC1 and mTORC2 play different roles in the functional survival of transplanted adipose-derived stromal cells in hind limb ischemic mice via regulating inflammation in vivo.
Fan W; Cheng K; Qin X; Narsinh KH; Wang S; Hu S; Wang Y; Chen Y; Wu JC; Xiong L; Cao F
Stem Cells; 2013 Jan; 31(1):203-14. PubMed ID: 23081858
[TBL] [Abstract][Full Text] [Related]
23. mTOR-what does it do?
Hall MN
Transplant Proc; 2008 Dec; 40(10 Suppl):S5-8. PubMed ID: 19100909
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of tumor cell growth, proliferation and migration by X-387, a novel active-site inhibitor of mTOR.
Chen SM; Liu JL; Wang X; Liang C; Ding J; Meng LH
Biochem Pharmacol; 2012 May; 83(9):1183-94. PubMed ID: 22305748
[TBL] [Abstract][Full Text] [Related]
25. [m-TOR inhibitors: biology and use in the treatment of haematological diseases].
Balsat M; Cornillon J
Bull Cancer; 2011 Aug; 98(8):935-43. PubMed ID: 21827982
[TBL] [Abstract][Full Text] [Related]
26. Activation of mTORC2 by association with the ribosome.
Zinzalla V; Stracka D; Oppliger W; Hall MN
Cell; 2011 Mar; 144(5):757-68. PubMed ID: 21376236
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of mTOR activity restores tamoxifen response in breast cancer cells with aberrant Akt Activity.
deGraffenried LA; Friedrichs WE; Russell DH; Donzis EJ; Middleton AK; Silva JM; Roth RA; Hidalgo M
Clin Cancer Res; 2004 Dec; 10(23):8059-67. PubMed ID: 15585641
[TBL] [Abstract][Full Text] [Related]
28. PI3K/mTOR signaling pathways in medulloblastoma.
Mohan AL; Friedman MD; Ormond DR; Tobias M; Murali R; Jhanwar-Uniyal M
Anticancer Res; 2012 Aug; 32(8):3141-6. PubMed ID: 22843885
[TBL] [Abstract][Full Text] [Related]
29. Rictor regulates MMP-9 activity and invasion through Raf-1-MEK-ERK signaling pathway in glioma cells.
Das G; Shiras A; Shanmuganandam K; Shastry P
Mol Carcinog; 2011 Jun; 50(6):412-23. PubMed ID: 21557327
[TBL] [Abstract][Full Text] [Related]
30. RAD 001 (everolimus) prevents mTOR and Akt late re-activation in response to imatinib in chronic myeloid leukemia.
Mancini M; Petta S; Martinelli G; Barbieri E; Santucci MA
J Cell Biochem; 2010 Feb; 109(2):320-8. PubMed ID: 20014066
[TBL] [Abstract][Full Text] [Related]
31. The role of mechanistic target of rapamycin in maintenance of glomerular epithelial cells.
Yao Y; Inoki K
Curr Opin Nephrol Hypertens; 2016 Jan; 25(1):28-34. PubMed ID: 26625863
[TBL] [Abstract][Full Text] [Related]
32. mTOR signalling: jack-of-all-trades
El Hiani Y; Egom EE; Dong XP
Biochem Cell Biol; 2019 Feb; 97(1):58-67. PubMed ID: 29768134
[TBL] [Abstract][Full Text] [Related]
33. mTORC2-Akt signaling axis is implicated in myocardial compensation and fibrosis.
Dany M; Rimmani HH; Matar SA; Hajj Hussein I
J Biol Regul Homeost Agents; 2015; 29(4):745-53. PubMed ID: 26753634
[TBL] [Abstract][Full Text] [Related]
34. [Role of the mTOR pathway in the central regulation of energy balance].
Haissaguerre M; Cota D
Biol Aujourdhui; 2015; 209(4):295-307. PubMed ID: 27021048
[TBL] [Abstract][Full Text] [Related]
35. mTORC1 regulates the efficiency and cellular capacity for protein synthesis.
Proud CG
Biochem Soc Trans; 2013 Aug; 41(4):923-6. PubMed ID: 23863157
[TBL] [Abstract][Full Text] [Related]
36. The Roles of mTOR Complexes in Lipid Metabolism.
Caron A; Richard D; Laplante M
Annu Rev Nutr; 2015; 35():321-48. PubMed ID: 26185979
[TBL] [Abstract][Full Text] [Related]
37. Kinase mTOR: regulation and role in maintenance of cellular homeostasis, tumor development, and aging.
Parkhitko AA; Favorova OO; Khabibullin DI; Anisimov VN; Henske EP
Biochemistry (Mosc); 2014 Feb; 79(2):88-101. PubMed ID: 24794724
[TBL] [Abstract][Full Text] [Related]
38. mTOR complex 1: a key player in neuroadaptations induced by drugs of abuse.
Neasta J; Barak S; Hamida SB; Ron D
J Neurochem; 2014 Jul; 130(2):172-84. PubMed ID: 24666346
[TBL] [Abstract][Full Text] [Related]
39. The Regulatory Effects of mTOR Complexes in the Differentiation and Function of CD4
Wang P; Zhang Q; Tan L; Xu Y; Xie X; Zhao Y
J Immunol Res; 2020; 2020():3406032. PubMed ID: 32377533
[TBL] [Abstract][Full Text] [Related]
40. Many roads from mTOR to eIF4F.
Thoreen CC
Biochem Soc Trans; 2013 Aug; 41(4):913-6. PubMed ID: 23863155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
